Organization
Erasmus University Medical Center
11 abstracts
Abstract
A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.Org: City of Hope National Medical Center, Erasmus University Medical Center, Institut Paoli-Calmettes, Marseille, France, University Medical Center Groningen, MD Anderson Cancer Center,
Abstract
Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study.Org: Miami Cancer Institute, Poznan University of Medical Sciences, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, General University Hospital in Prague,
Abstract
Circulating tumor cells and tumor DNA in patients with resectable colorectal liver metastases: The MIRACLE.Org: Erasmus MC Cancer Institute, Erasmus University Medical Center, Albert Schweitzer Hospital, IJsselland Hospital, Amphia Hospital,
Abstract
Genome-wide aneuploidy detected in circulating cell-free DNA of patients with metastatic urothelial cancer as a predictive biomarker of response to pembrolizumab.Org: Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Erasmus University Rotterdam, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Amphia Hospital, Cancer Center Amsterdam,
Abstract
Nationwide implementation of best practices in pancreatic cancer care (PACAP-1): Stepped-wedge cluster randomized trial.Org: Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands, University of Amsterdam, Netherlands Comprehensive Cancer Organisation (IKNL), Department of Surgery, Brigham and Women's Hospital, Boston, MA, Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan,
Abstract
mFAST-SeqS based aneuploidy score in circulating cell-free DNA and role as early response marker in patients with metastatic prostate cancer treated with androgen receptor signaling inhibitor.Org: Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Franciscus Gasthuis & Vlietland, Erasmus University Medical Center,
Abstract
An indirect comparison of elranatamab’s (ELRA) objective response rate (ORR) from MagnetisMM-3 (MM-3) vs real-world external control arms in triple-class refractory (TCR) multiple myeloma (MM).Org: University of Alabama at Birmingham Department of Hematology, Birmingham, AL, Duke University School of Medicine, Department of Head and Neck Surgery & Communication Sciences, Durham, NC, Bethanien Hospital, Erasmus University Medical Center, Statlog,
Abstract
The impact of emotional distress on pathologic response and survival after neoadjuvant combination immune checkpoint blockade (ICB) in high-risk stage III melanoma.Org: Netherlands Cancer Institute, Division of Psychosocial Oncology and Epidemiology, Core Facility Molecular Pathology and Biobanking, Melanoma Institute Australia, The University of Sydney,
Abstract
Analysis of significant weight gain in patients using alectinib for ALK-positive lung cancer.Org: Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Erasmus MC University Medical Center, Erasmus Medical Center, Erasmus MC Kankerinstituut, Department of Pulmonary Medicine,
Abstract
ACHIEVING A LOW DAS IN THE FIRST 4-MONTHS AFTER DIAGNOSIS IS IMPORTANT FOR THE LONG-TERM CHANCE OF ACHIEVING DMARD-FREE REMISSIONOrg: Leiden University Medical Center, Erasmus University Medical Center,
Abstract
BIOLOGICAL MANAGEMENT IN RHEUMATOID ARTHRITIS: RESULTS OF A REAL-WORLD COHORT FROM THE NETHERLANDSOrg: Erasmus University Medical Center,